IMUC Company Profile and Key Details

Q: Who are the executives of IMUC?

Mr. Wayne I. Danson CPAChief Financial Officer & TreasurerDr. Irach B. Taraporewala B.S., M.S., Ph.D.Chief Executive Officer, Pres & DirectorMr. Eli GoldbergerFounder, Chairman & Chief Operating OfficerDr. Shalom Z. Hirschman M.D.Co-Founder, Chief Scientific Officer & Medical Director

PNK : IMUC

ImmunoCellular Therapeutics

$0.19

0.079+71.17%

At Close 4:00 PM

Profile Key Stats Analyst Ratings Ownership Ratios Financials Dividend & splits Sentiment Forecast

Price Chart

Stock Price Today

EOM Pharmaceuticals Holdings, Inc. (IMUC) stock surged +0.66%, trading at $0.15 on OTC, up from the previous close of $0.15. The stock opened at $0.15, fluctuating between $0.15 and $0.15 in the recent session.

Stock Snapshot

0.151

Prev. Close

19.23M

Market Cap

0.152

Day Low

-0.03

P/E Ratio

-4.4029

EPS (TTM)

N/A

Cash Flow per Share

0.15

Open

126.5M

Number of Shares

0.1521

Day High

99.71%

Free Float in %

N/A

Book Value

100

Volume

Relevant Articles

SEC Fillings

Current Report (8-k)

Filing Date	Accepted Date

Annual Report (10-k)

Filing Date	Accepted Date

Stock Price History Chart

Date	Open	High	Low	Close	Volume
Sep 10, 2026	0.15	0.15	0.15	0.15	303
Sep 09, 2026	0.15	0.15	0.15	0.15	110
Sep 08, 2026	0.20	0.20	0.20	0.20	100
Sep 04, 2026	0.15	0.15	0.15	0.15	200
Sep 03, 2026	0.15	0.15	0.15	0.15	1.06K
Sep 01, 2026	0.14	0.14	0.14	0.14	117
Aug 31, 2026	0.14	0.20	0.14	0.20	1.27K
Aug 19, 2026	0.13	0.13	0.13	0.13	1K
Aug 18, 2026	0.20	0.20	0.20	0.20	50
Aug 17, 2026	0.13	0.13	0.13	0.13	119
Aug 14, 2026	0.16	0.20	0.16	0.20	348
Aug 13, 2026	0.15	0.15	0.13	0.13	20.01K
Aug 11, 2026	0.24	0.24	0.24	0.24	138
Aug 04, 2026	0.14	0.22	0.13	0.22	1.77K
Jul 31, 2026	0.13	0.23	0.13	0.23	14.07K
Jul 28, 2026	0.23	0.23	0.13	0.13	1.41K
Jul 27, 2026	0.24	0.24	0.24	0.24	3.69K
Jul 24, 2026	0.21	0.21	0.21	0.21	800
Jul 22, 2026	0.25	0.25	0.25	0.25	110
Jul 21, 2026	0.13	0.13	0.13	0.13	569

Contact Details

Montvale, NJ 07645

United States

https://www.eompharma.com 201 351 0605

About Company

EOM Pharmaceuticals Holdings, Inc., a clinical-stage biotechnology company, focuses on the development of drugs to transform therapeutic paradigms and enhance quality of life in patients suffering from debilitating and deadly diseases in the United States. The company’s lead compound is EOM613, a peptide nucleic-acid solution with both anti-inflammatory and pro-inflammatory broad spectrum cytokine effects that has completed Phase 2 clinical trials for the treatment of cancer cachexia, AIDS/cancer cachexia, HIV/AIDS, and rheumatoid arthritis, as well as in Phase ½ a clinical trial to treat infectious diseases, such as COVID-19. It also develops EOM 147, an investigational broad-spectrum aminosterol with an intracellular mechanism that has completed Phase 2 clinical trial for the treatment of age-related macular degeneration, diabetic retinopathy, and macular edema due to retinal vain occlusion. EOM Pharmaceuticals Holdings, Inc. was founded in 2020 and is headquartered in Montvale, New Jersey.

Stock Peers

LZAGF

-5-0.92%

Lonza Group AG$541.00 GNMSF

Genmab A/S$268.61 CMXHF

CSL Limited$192.00 CSLLY

0.75+0.79%

CSL Limited$95.35 UCBJY

-0.06-0.08%

UCB SA$73.15 LZAGY

-0.33-0.61%

Lonza Group AG$53.87 PHMMF

4.3+16.01%

Pharma Mar, S.A.$31.15 BVNKF

Bavarian Nordic A/S$21.20 GRTX

1.53+9.80%

Galera Therapeutics, Inc.$17.15 NURPF

Neuren Pharmaceuticals Limited$14.00

Frequently Asked Questions

What is the current ImmunoCellular Therapeutics, Ltd. (IMUC) stock price?

ImmunoCellular Therapeutics, Ltd. (OTC: IMUC) stock price is $0.15 in the last trading session. During the trading session, IMUC stock reached the peak price of $0.15 while $0.15 was the lowest point it dropped to. The percentage change in IMUC stock occurred in the recent session was 0.66% while the dollar amount for the price change in IMUC stock was $0.00.

IMUC's industry and sector of operation?

The OTC listed IMUC is part of Biotechnology industry that operates in the broader Healthcare sector. ImmunoCellular Therapeutics, Ltd. designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.

Who are the executives of IMUC?

Mr. Wayne I. Danson CPA
Chief Financial Officer & Treasurer
Dr. Irach B. Taraporewala B.S., M.S., Ph.D.
Chief Executive Officer, Pres & Director
Mr. Eli Goldberger
Founder, Chairman & Chief Operating Officer
Dr. Shalom Z. Hirschman M.D.
Co-Founder, Chief Scientific Officer & Medical Director

How IMUC did perform over past 52-week?

IMUC's closing price is 90% higher than its 52-week low of $0.04 where as its distance from 52-week high of $0.34 is -52.5%.

How many employees does IMUC have?

Number of IMUC employees currently stands at 3.

Link for IMUC official website?

Official Website of IMUC is: https://www.eompharma.com

How do I contact IMUC?

IMUC could be contacted at phone 201 351 0605 and can also be accessed through its website. IMUC operates from 136 Summit Avenue, Montvale, NJ 07645, United States.

How many shares of IMUC are traded daily?

IMUC stock volume for the day was 100 shares. The average number of IMUC shares traded daily for last 3 months was 1.37K.

What is the market cap of IMUC currently?

The market value of IMUC currently stands at $19.23M with its latest stock price at $0.15 and 126.5M of its shares outstanding.

Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.

Stocks Telegraph does not provide any advice or recommendations for buying or selling stocks, securities, or other financial products. Information contained on this website is for informational purposes only and should not be construed as professional financial, investment or other advice. Stocks Telegraph is not liable for any loss or damage that may occur as a result of reliance on this data.

Employees	3
Beta	0.17
Sales or Revenue	$0.00
5Y Sales Change%	0%
Fiscal Year Ends	December
Sector	Healthcare
Industry	Biotechnology

Employees	3
Beta	0.17
Sales or Revenue	$0.00
5Y Sales Change%	0%
Fiscal Year Ends	December
Sector	Healthcare
Industry	Biotechnology

IMUC Company Profile and Key Details

ImmunoCellular Therapeutics

Price Chart

Stock Price Today

Stock Snapshot

Relevant Articles

SEC Fillings

Current Report (8-k)

Annual Report (10-k)

Stock Price History Chart

Contact Details

About Company

Company Information

Stock Peers

Frequently Asked Questions

Price Chart

Stock Price Today

Stock Snapshot

Relevant Articles

SEC Fillings

Current Report (8-k)

Annual Report (10-k)

Stock Price History Chart

Contact Details

About Company

Company Information

Stock Peers

Company Overview

Technical Performance

Valuation Metrics

Dividend & Fair Value

Shareholding & Insider Activity

Financial & Profitability Overview

Quarterly Financial Highlights

Price Forecast & Outlook

Key Takeaways

Frequently Asked Questions

Company Overview

Technical Performance

Shareholding & Insider Activity

Dividend & Fair Value

Financial & Profitability Overview

Quarterly Financial Highlights

Price Forecast & Outlook

Key Takeaways

Valuation Metrics